34299592|t|Structural and Functional Impairments of Reconstituted High-Density Lipoprotein by Incorporation of Recombinant beta-Amyloid42.
34299592|a|Beta (beta)-amyloid (Abeta) is a causative protein of Alzheimer's disease (AD). In the pathogenesis of AD, the apolipoprotein (apo) A-I and high-density lipoprotein (HDL) metabolism is essential for the clearance of Abeta. In this study, recombinant Abeta42 was expressed and purified via the pET-30a expression vector and E.coli production system to elucidate the physiological effects of Abeta on HDL metabolism. The recombinant human Abeta protein (51 aa) was purified to at least 95% purity and characterized in either the lipid-free and lipid-bound states with apoA-I. Abeta was incorporated into the reconstituted HDL (rHDL) (molar ratio 95:5:1, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC):cholesterol:apoA-I) with various apoA-I:Abeta ratios from 1:0 to 1:0.5, 1:1 and 1:2. With an increasing molar ratio of Abeta, the alpha-helicity of apoA-I was decreased from 62% to 36% with a red shift of the Trp wavelength maximum fluorescence from 337 to 340 nm in apoA-I. The glycation reaction of apoA-I was accelerated further by the addition of Abeta. The treatment of fructose and Abeta caused more multimerization of apoA-I in the lipid-free state and in HDL. The phospholipid-binding ability of apoA-I was impaired severely by the addition of Abeta in a dose-dependent manner. The phagocytosis of LDL into macrophages was accelerated more by the presence of Abeta with the production of more oxidized species. Abeta severely impaired tissue regeneration, and a microinjection of Abeta enhanced embryotoxicity. In conclusion, the beneficial functions of apoA-I and HDL were severely impaired by the addition of Abeta via its detrimental effect on secondary structure. The impairment of HDL functionality occurred more synergistically by means of the co-addition of fructose and Abeta.
34299592	11	37	and Functional Impairments	Disease	MESH:D003072
34299592	149	154	Abeta	Gene	351
34299592	182	201	Alzheimer's disease	Disease	MESH:D000544
34299592	203	205	AD	Disease	MESH:D000544
34299592	231	233	AD	Disease	MESH:D000544
34299592	239	263	apolipoprotein (apo) A-I	Gene	335
34299592	344	349	Abeta	Gene	351
34299592	378	385	Abeta42	Gene	351
34299592	451	457	E.coli	Species	562
34299592	518	523	Abeta	Gene	351
34299592	559	564	human	Species	9606
34299592	655	660	lipid	Chemical	MESH:D008055
34299592	670	675	lipid	Chemical	MESH:D008055
34299592	694	701	apoA-I.	Gene	335
34299592	702	707	Abeta	Gene	351
34299592	778	828	, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine	Chemical	MESH:C028694
34299592	830	834	POPC	Chemical	MESH:C065191
34299592	836	847	cholesterol	Chemical	MESH:D002784
34299592	848	854	apoA-I	Gene	335
34299592	869	875	apoA-I	Gene	335
34299592	876	881	Abeta	Gene	351
34299592	955	960	Abeta	Gene	351
34299592	984	990	apoA-I	Gene	335
34299592	1045	1048	Trp	Chemical	MESH:D014364
34299592	1103	1110	apoA-I.	Gene	335
34299592	1137	1143	apoA-I	Gene	335
34299592	1187	1192	Abeta	Gene	351
34299592	1211	1219	fructose	Chemical	MESH:D005632
34299592	1224	1229	Abeta	Gene	351
34299592	1261	1267	apoA-I	Gene	335
34299592	1275	1280	lipid	Chemical	MESH:D008055
34299592	1308	1320	phospholipid	Chemical	MESH:D010743
34299592	1340	1346	apoA-I	Gene	335
34299592	1388	1393	Abeta	Gene	351
34299592	1503	1508	Abeta	Gene	351
34299592	1555	1560	Abeta	Gene	351
34299592	1624	1629	Abeta	Gene	351
34299592	1639	1653	embryotoxicity	Disease	
34299592	1698	1704	apoA-I	Gene	335
34299592	1755	1760	Abeta	Gene	351
34299592	1909	1917	fructose	Chemical	MESH:D005632
34299592	1922	1927	Abeta	Gene	351
34299592	Positive_Correlation	MESH:D005632	335
34299592	Association	335	351
34299592	Association	MESH:D008055	335
34299592	Association	MESH:D010743	351
34299592	Association	MESH:D010743	335
34299592	Association	MESH:D000544	351

